Table 2a.

Durations and delays among new and retreatment patients.

	New (n = 49)	Retreatment (n = 15)	Entire cohort (n = 64)
Total patient pathway
Duration < 35 days	32 (65%)	9 (60%)	41 (64%)
Duration ≥ 35 days	17 (35%)	6 (40%)	23 (36%)
Mean in days (range)	41 (1–164)	38 (8–90)	40 (1–164)
Median in days	27	26	27
First care seeking
Duration < 15 days	34 (69%)	10 (67%)	44 (69%)
Duration ≥ 15 days	15 (31%)	5 (33%)	20 (31%)
Mean in days (range)	15 (0–122)	16 (0–61)	15 (0–122)
Median in days	7	13	9
Diagnostic delay
Duration < 15 days	31 (63%)	9 (60%)	40 (62%)
Duration ≥ 15 days	18 (37%)	6 (40%)	24 (38%)
Mean in days (range)	24 (0–131)	22 (1–71)	23 (0 – 131)
Median in days	9	8	9
Treatment initiation
Duration < 7 days	44 (90%)	15 (100%)	59 (92%)
Duration > 7 days	5 (10%)	0	5 (8%)
Mean in days (range)	2 (0–30)	0 (0–5)	2 (0–30)
Median in days	0	0	0